Anna Baginska

534 total citations
13 papers, 315 citations indexed

About

Anna Baginska is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Anna Baginska has authored 13 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Anna Baginska's work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Inflammasome and immune disorders (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Anna Baginska is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Inflammasome and immune disorders (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Anna Baginska collaborates with scholars based in United Kingdom, Spain and Germany. Anna Baginska's co-authors include Dorota Rowczenio, Helen J. Lachmann, Philip N. Hawkins, Hadija Trojer, Thirusha Lane, Ebun Omoyinmi, Paul Brogan, Anna Mensa‐Vilaró, Juan I. Aróstegui and Sinisa Savic and has published in prestigious journals such as Blood, Frontiers in Immunology and Lara D. Veeken.

In The Last Decade

Anna Baginska

13 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Baginska United Kingdom	7	256	134	75	73	45	13	315
Hadija Trojer United Kingdom	7	282 1.1×	168 1.3×	80 1.1×	78 1.1×	52 1.2×	14	346
Evelien J. Bodar Netherlands	5	402 1.6×	214 1.6×	114 1.5×	187 2.6×	61 1.4×	8	469
Y Hamano Japan	5	74 0.3×	206 1.5×	54 0.7×	50 0.7×	43 1.0×	8	319
V. Martínez-Taboada Spain	7	131 0.5×	111 0.8×	130 1.7×	72 1.0×	16 0.4×	11	280
Jamil Al-Alami Jordan	6	302 1.2×	105 0.8×	68 0.9×	28 0.4×	25 0.6×	13	419
Oskar Schnappauf United States	7	291 1.1×	182 1.4×	39 0.5×	38 0.5×	47 1.0×	9	381
Rozenn Le Corre France	11	80 0.3×	174 1.3×	80 1.1×	28 0.4×	27 0.6×	21	304
Laura Dickie United Kingdom	7	245 1.0×	242 1.8×	78 1.0×	94 1.3×	36 0.8×	11	405
Simanta Pathak United States	9	121 0.5×	210 1.6×	70 0.9×	62 0.8×	6 0.1×	12	371
Laurent Messer France	8	103 0.4×	70 0.5×	97 1.3×	28 0.4×	27 0.6×	14	214

Countries citing papers authored by Anna Baginska

Since Specialization

Citations

This map shows the geographic impact of Anna Baginska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Baginska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Baginska more than expected).

Fields of papers citing papers by Anna Baginska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Baginska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Baginska. The network helps show where Anna Baginska may publish in the future.

Co-authorship network of co-authors of Anna Baginska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Baginska. A scholar is included among the top collaborators of Anna Baginska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Baginska. Anna Baginska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Baginska, Anna, Igor Cima, Sied Kebir, et al.. (2023). KDM5B predicts temozolomide-resistant subclones in glioblastoma. iScience. 27(1). 108596–108596. 2 indexed citations

Rowczenio, Dorota, Taryn Youngstein, Hadija Trojer, et al.. (2019). British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature. Lara D. Veeken. 59(3). 554–558. 14 indexed citations

Serçin, Özdemirhan, Sabine Reither, Anna Baginska, et al.. (2019). A solid‐phase transfection platform for arrayed CRISPR screens. Molecular Systems Biology. 15(12). e8983–e8983. 7 indexed citations

Rowczenio, Dorota, Candida Cristina Quarta, Marianna Fontana, et al.. (2018). Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience. Human Mutation. 40(1). 90–96. 29 indexed citations

Rowczenio, Dorota, Sónia Gomes, Juan I. Aróstegui, et al.. (2017). Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience. Frontiers in Immunology. 8. 1410–1410. 95 indexed citations

Rowczenio, Dorota, Shelly Pathak, Juan I. Aróstegui, et al.. (2017). Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome. Blood. 131(9). 974–981. 68 indexed citations

Rowczenio, Dorota, Hadija Trojer, Ebun Omoyinmi, et al.. (2016). Brief Report: Association of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24‐Nucleotide TNFRSF1A Deletion. Arthritis & Rheumatology. 68(8). 2044–2049. 43 indexed citations

Coyne, Mark, Anna Baginska, Dorota Rowczenio, & Ashutosh Wechalekar. (2015). Evaluating the use of Multiparametric Flow Cytometry in establishing the presence of Minimal Residual Disease in systemic AL amyloidosis: a report of eight patients. Clinical Lymphoma Myeloma & Leukemia. 15. e185–e185. 1 indexed citations

Sachchithanantham, Sajitha, Ruth M. de Tute, Anna Baginska, et al.. (2014). The Prognostic Significance of Phenotypically ‘Normal’ Plasma Cells in Chemotherapy Treated AL Patients with Underlying MGUS and Multiple Myeloma. Blood. 124(21). 2073–2073. 1 indexed citations

10.

Boyle, Eileen M., Brian A. Walker, Christopher P. Wardell, et al.. (2014). Exome Sequencing to Define a Genetic Signature of Plasma Cells in Systemic AL Amyloidosis. Blood. 124(21). 726–726. 4 indexed citations

11.

Sachchithanantham, Sajitha, Anna Baginska, Dorota Rowczenio, et al.. (2013). Use Of Plasma Cell Immunophenotype As Prognostic Markers In Patients With Systemic AL Amyloidosis. Blood. 122(21). 3120–3120. 5 indexed citations

12.

Rowczenio, Dorota, Hadija Trojer, Tonia Russell, et al.. (2013). Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature. Arthritis Research & Therapy. 15(1). R30–R30. 43 indexed citations

13.

Walker, Brian A., Eileen M. Boyle, Christopher P. Wardell, et al.. (2013). Exome Sequencing To Define A Genetic Signature Of Plasma Cells In Systemic AL Amyloidosis. Blood. 122(21). 3098–3098. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact